128 related articles for article (PubMed ID: 2955032)
1. Screening of antiviral drugs for treatment of hepatitis B.
Tsiquaye KN; Collins P; Zuckerman AJ
J Hepatol; 1986; 3 Suppl 2():S45-8. PubMed ID: 2955032
[No Abstract] [Full Text] [Related]
2. Foscarnet in fulminant hepatitis B.
Price JS; France AJ; Moaven LD; Welsby PD
Lancet; 1986 Nov; 2(8518):1273. PubMed ID: 2878146
[No Abstract] [Full Text] [Related]
3. Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet.
Hedin G; Weiland O; Ljunggren K; Strömberg A; Nordenfelt E; Hansson BG; Oberg B
Prog Clin Biol Res; 1987; 234():309-20. PubMed ID: 2957702
[No Abstract] [Full Text] [Related]
4. Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
Al-Samarai A; Kinghorn G; Potter C
Chemioterapia; 1987 Jun; 6(2 Suppl):665-6. PubMed ID: 2855616
[No Abstract] [Full Text] [Related]
5. [Treatment of cytomegalovirus infections in immunosuppressed patients].
Michon C; Girard PM; Ngovan P; Simonpoli AM; Le Hoang P
Ann Med Interne (Paris); 1988; 139(7):511-5. PubMed ID: 2854380
[No Abstract] [Full Text] [Related]
6. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks.
Sherker AH; Hirota K; Omata M; Okuda K
Gastroenterology; 1986 Oct; 91(4):818-24. PubMed ID: 2943628
[TBL] [Abstract][Full Text] [Related]
7. Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.
MacPhail LA; Greenspan D; Schiødt M; Drennan DP; Mills J
Oral Surg Oral Med Oral Pathol; 1989 Apr; 67(4):427-32. PubMed ID: 2524706
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
Chatis PA; Miller CH; Schrager LE; Crumpacker CS
N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
[No Abstract] [Full Text] [Related]
9. Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis.
Jacobson MA; Mills J; Rush J; O'Donnell JJ; Miller RG; Greco C; Gonzales MF
Arch Neurol; 1988 Oct; 45(10):1090-2. PubMed ID: 2845899
[TBL] [Abstract][Full Text] [Related]
10. Foscarnet for cytomegalovirus infections.
Ringdén O; Wilczek H; Lönnqvist B; Gahrton G; Wahren B; Lernestedt JO
Lancet; 1985 Jun; 1(8444):1503-4. PubMed ID: 2861426
[No Abstract] [Full Text] [Related]
11. Acyclovir-resistant herpes in AIDS treated with foscarnet.
Youle MM; Hawkins DA; Collins P; Shanson DC; Evans R; Oliver N; Lawrence A
Lancet; 1988 Aug; 2(8606):341-2. PubMed ID: 2899762
[No Abstract] [Full Text] [Related]
12. Postexposure treatment of experimental DHBV infection: a new therapeutic strategy.
Freiman JS; Murray SM; Vickery K; Lim D; Cossart YE
J Med Virol; 1990 Apr; 30(4):272-6. PubMed ID: 2142501
[TBL] [Abstract][Full Text] [Related]
13. Foscarnet for cytomegalovirus retinitis.
Singer DR; Fallon TJ; Schulenburg WE; Williams G; Cohen J
Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):962. PubMed ID: 2998255
[No Abstract] [Full Text] [Related]
14. The potential of phosphonoformate for the treatment of herpex simplex labialis.
Oxford J
J Antimicrob Chemother; 1980 Nov; 6(6):694-5. PubMed ID: 6449499
[No Abstract] [Full Text] [Related]
15. [Importance of Foscarnet in the treatment of cytomegalovirus pneumopathy in a patient with acquired immunodeficiency syndrome].
Brochard L; Salmeron S; Herve P; Petitpretz P; Boissonnas A; Simonneau G; Duroux P
Presse Med; 1986 Nov; 15(40):2022-3. PubMed ID: 3025830
[No Abstract] [Full Text] [Related]
16. [Chemotherapy of cytomegalovirus infections].
Sakuma T; Azuma M
Nihon Rinsho; 1989 Feb; 47(2):384-9. PubMed ID: 2542662
[No Abstract] [Full Text] [Related]
17. Foscarnet.
Lancet; 1985 Sep; 2(8456):648-9. PubMed ID: 2863637
[No Abstract] [Full Text] [Related]
18. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
Erlich KS; Jacobson MA; Koehler JE; Follansbee SE; Drennan DP; Gooze L; Safrin S; Mills J
Ann Intern Med; 1989 May; 110(9):710-3. PubMed ID: 2522751
[TBL] [Abstract][Full Text] [Related]
19. Declining levels of HIV P24 antigen in serum during treatment with foscarnet.
Bergdahl S; Sönnerborg A; Larsson A; Strannegard O
Lancet; 1988 May; 1(8593):1052. PubMed ID: 2896890
[No Abstract] [Full Text] [Related]
20. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J
J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
